PHARMACIA CORP /DE/
8-K, 2000-11-01
CHEMICALS & ALLIED PRODUCTS
Previous: MINNESOTA MINING & MANUFACTURING CO, 10-Q, EX-27, 2000-11-01
Next: PHARMACIA CORP /DE/, 8-K, EX-99, 2000-11-01

    As filed with the Securities and Exchange Commission on October 31, 2000


                       SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549


                                    FORM 8-K


                             Current Report Pursuant
                          to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934



Date of report (Date of earliest event reported)  November 1, 2000              


                             PHARMACIA CORPORATION                              
             (Exact Name of Registrant as Specified in Its Charter)


                                    Delaware                                    
                 (State or Other Jurisdiction of Incorporation)


        1-2516                                            43-0420020            
(Commission File Number)                       (IRS Employer Identification No.)

100 Route 206 North, Peapack, New Jersey                            07977       
(Address of Principal Executive Offices)                          (Zip Code)

                                 (908) 901-8000                                 
              (Registrant's Telephone Number, Including Area Code)


                                       N/A                                      
          (Former Name or Former Address, if Changed Since Last Report)




Item 5.  Other Events.

         Pharmacia Corporation ("Pharmacia") is filing this Current Report on
Form 8-K to report its preliminary results of operations for the third quarter
of 2000. On October 30, 2000, Pharmacia issued a press release describing its
results of operations for the third quarter of 2000. The press release is
attached hereto as Exhibit 99, and is incorporated as part of this Current
Report on Form 8-K.



Item 7.  Financial Statements, Pro Forma Financial Information and Exhibits.


          The following exhibit is filed as part of this Current Report on Form
8-K:

Exhibit No.                    Exhibit

    99           Press Release of October 30, 2000








                                   SIGNATURES


         Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.



                                       PHARMACIA CORPORATION



Dated: November 1, 2000                By: /s/ Don W. Schmitz                   
                                          Name:  Don W. Schmitz
                                          Title:  Vice President, Associate
                                                  General Counsel and Corporate
                                                  Secretary







                                INDEX TO EXHIBITS



Exhibit No.      Exhibit

    99           Press Release dated October 30, 2000




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission